These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overview of pharmacogenetics. Katz DA; Bhathena A Curr Protoc Hum Genet; 2009 Jan; Chapter 9():Unit 9.19. PubMed ID: 19170034 [TBL] [Abstract][Full Text] [Related]
4. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing. Lauschke VM; Ingelman-Sundberg M Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656 [TBL] [Abstract][Full Text] [Related]
5. The hunt for new genes and polymorphisms that can control the response to drugs. Sheffield LJ Pharmacogenomics; 2002 Sep; 3(5):679-86. PubMed ID: 12223052 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and drug metabolism. Ball S; Borman N Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033 [No Abstract] [Full Text] [Related]
7. PharmGKB: understanding the effects of individual genetic variants. Sangkuhl K; Berlin DS; Altman RB; Klein TE Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600 [TBL] [Abstract][Full Text] [Related]
8. Pharmacoepigenetics: its role in interindividual differences in drug response. Gomez A; Ingelman-Sundberg M Clin Pharmacol Ther; 2009 Apr; 85(4):426-30. PubMed ID: 19242404 [No Abstract] [Full Text] [Related]
10. Effect of pharmacogenetics on medicine. Weber WW Environ Mol Mutagen; 2001; 37(3):179-84. PubMed ID: 11317335 [TBL] [Abstract][Full Text] [Related]
11. HapMap, pharmacogenomics, and the goal of personalized prescribing. O'Shaughnessy KM Br J Clin Pharmacol; 2006 Jun; 61(6):783-6. PubMed ID: 16722846 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics: past, present and future. Pirmohamed M Drug Discov Today; 2011 Oct; 16(19-20):852-61. PubMed ID: 21884816 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of pharmacoecology: which route to personalized medicine? Robertson GR; Grant DM; Piquette-Miller M Clin Pharmacol Ther; 2009 Apr; 85(4):343-8. PubMed ID: 19295529 [No Abstract] [Full Text] [Related]
14. Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics. Thelma B; Srivastava V; Tiwari AK Pharmacogenomics; 2008 Sep; 9(9):1285-306. PubMed ID: 18781856 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic importance of ABCG2. Cusatis G; Sparreboom A Pharmacogenomics; 2008 Aug; 9(8):1005-9. PubMed ID: 18681776 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics, pharmacogenomics, and individualized medicine. Ma Q; Lu AY Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics: the influence of genomic variation on drug response. Thomas FJ; McLeod HL; Watters JW Curr Top Med Chem; 2004; 4(13):1399-409. PubMed ID: 15379653 [TBL] [Abstract][Full Text] [Related]
18. How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments. De Gregori M; Allegri M; De Gregori S; Garbin G; Tinelli C; Regazzi M; Govoni S; Ranzani GN Curr Drug Metab; 2010 Mar; 11(3):276-82. PubMed ID: 21171195 [TBL] [Abstract][Full Text] [Related]
19. Challenges for kinetic identification of variability associated with genetic polymorphisms of transporters. Chung SJ Drug Metab Pharmacokinet; 2010; 25(5):409-10. PubMed ID: 21071879 [No Abstract] [Full Text] [Related]
20. Laying the foundations for personalized medicines. Marshall A Nat Biotechnol; 1997 Oct; 15(10):954-7. PubMed ID: 9335043 [No Abstract] [Full Text] [Related] [Next] [New Search]